This is a discussion on DRAFT REPORT: Comparative Effectiveness of Lipid Modifying Agents within the Comparative Effectiveness Updates forum, part of the Industry News and Updates category; Draft report on the comparative effectiveness of lipid modifying agents has been posted by the AHRQ. The key objective was ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
||||
|
Draft report on the comparative effectiveness of lipid modifying agents has been posted by the AHRQ. The key objective was to compare efficacy, safety, and effectiveness of statin combination therapies with higher dose statin monotherapy.
The AHRQ is accepting comments on this draft document until October 3, 2008 at the following link. |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Value of comparative effectiveness reviews | diana.papshev | Managed Care Pharmacy Administrative Issues | 4 | 07-31-2008 03:39 PM |
| Assessing the Need to Update Comparative Effectiveness Research Reviews | industry_news | Comparative Effectiveness Updates | 0 | 07-09-2008 08:23 AM |
| DRAFT: Methods Reference Guide for Effectiveness and Comparative Effectiveness Reviews | industry_news | Comparative Effectiveness Updates | 0 | 04-10-2008 08:22 PM |
| Comparative Effectiveness of Beta Adrenergic Antagonists on the Risk of Rehospitaliza | industry_news | Comparative Effectiveness Updates | 0 | 03-10-2008 04:01 PM |
| Comparative Effectiveness of Treatments To Prevent Fractures in Men and Women With Lo | industry_news | Comparative Effectiveness Updates | 0 | 03-10-2008 04:01 PM |